Search research articles
Contact Us
Filters
Showing results (41-50 of 226) with videos related to
Page
of 23
Sort By:
Current Opinion in Immunology
|
February 2, 2010
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Tyler R Simpson, Sergio A Quezada, James P Allison
Cancer Immunity
|
August 17, 2012
Monoclonal antibodies in cancer therapy
Andrew M Scott, James P Allison, Jedd D Wolchok
Plos Biology
|
September 22, 2010
Attenuated T cell responses to a high-potency ligand in vivo
Emily Corse, Rachel A Gottschalk, Michelle Krogsgaard, et al.
The Journal of Experimental Medicine
|
May 11, 2021
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
Naveen Sharma, Oluwatomisin T Atolagbe, Zhongqi Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2010
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A Curran, Welby Montalvo, Hideo Yagita, et al.
Cancer Immunity
|
August 17, 2012
An open invitation to the cancer immunology community
Pramod K Srivastava, Vincenzo Cerundolo, Alexander Knuth, et al.
Nature Reviews. Cancer
|
October 25, 2011
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma, Klaus Wagner, Jedd D Wolchok, et al.
Immunity
|
September 11, 2004
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse
Tsvetelina Pentcheva-Hoang, Jackson G Egen, Kathleen Wojnoonski, et al.
Blood Cancer Discovery
|
January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?
Spencer C Wei, James J Mancuso, Naval Daver, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2007
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
Tsvetelina Pentcheva-Hoang, Lieping Chen, Drew M Pardoll, et al.
Page
of 23
Search research articles
Search
Showing results (41-50 of 226) with videos related to
Sort By:
Page
of 23
Current Opinion in Immunology
|
February 2, 2010
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Tyler R Simpson, Sergio A Quezada, James P Allison
Cancer Immunity
|
August 17, 2012
Monoclonal antibodies in cancer therapy
Andrew M Scott, James P Allison, Jedd D Wolchok
Plos Biology
|
September 22, 2010
Attenuated T cell responses to a high-potency ligand in vivo
Emily Corse, Rachel A Gottschalk, Michelle Krogsgaard, et al.
The Journal of Experimental Medicine
|
May 11, 2021
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
Naveen Sharma, Oluwatomisin T Atolagbe, Zhongqi Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2010
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A Curran, Welby Montalvo, Hideo Yagita, et al.
Cancer Immunity
|
August 17, 2012
An open invitation to the cancer immunology community
Pramod K Srivastava, Vincenzo Cerundolo, Alexander Knuth, et al.
Nature Reviews. Cancer
|
October 25, 2011
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma, Klaus Wagner, Jedd D Wolchok, et al.
Immunity
|
September 11, 2004
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse
Tsvetelina Pentcheva-Hoang, Jackson G Egen, Kathleen Wojnoonski, et al.
Blood Cancer Discovery
|
January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?
Spencer C Wei, James J Mancuso, Naval Daver, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2007
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
Tsvetelina Pentcheva-Hoang, Lieping Chen, Drew M Pardoll, et al.
Page
of 23